“Effect of Subcutaneous Spesolimab on the Prevention of Generalized Pustular Psoriasis Flares Over 48 Weeks: Subgroup Analyses from the Effisayil 2 Trial ”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s245, https://doi.org/10.25251/skin.7.supp.245.